4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $14.00K in the quarter ending March 31, 2025, a decrease of -50.00%. This brings the company's revenue in the last twelve months to $23.00K, down -99.89% year-over-year. In the year 2024, 4D Molecular Therapeutics had annual revenue of $37.00K, down -99.82%.

• Revenue (ttm): $23.00K
• Revenue Growth: -99.89%
• P/S Ratio: 6,686.86
• Revenue / Employee: $101
• Employees: 227
• Market Cap: 153.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.00K	-20.69M	-99.82%
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.